<i>In vivo</i>, the combination of radiotherapy and magnetic fluid hyperthermia applied together with a GOX-containing, anti-CD61-functionalized magnetic nanoplatform was associated with improved therapeutic outcomes in the lung cancer model. This evidence concerns the gene ITGB3 and lung carcinoma.